Menarini group and stemline therapeutics inc Today announced a definitive agreement under which menarini group will acquire stemline in a transaction valued up to $677 million. Explore stemline therapeutics' medical portal, featuring menarini oncology’s pipeline, clinical trial updates, product information, and key resources for healthcare professionals. Stemline therapeutics, a part of the menarini group, is focused on the development and commercialization of novel oncology therapeutics.
OPEN